קניה - אנגלית - Pharmacy and Poisons Board

mylan laboratories limited c/o. surgilinks ltd mylan laboratories limited, plot no.564/a/22, - abacavir sulfate and lamivudine - film-coated tablet - abacavir sulfate 600mg / lamivudine 300mg - lamivudine and abacavir

קניה - אנגלית - Pharmacy and Poisons Board

abacavir sulfate and lamivudine tablets for oral… - tablet for oral suspension - abacavir sulfate usp equivalent to abacavir… - lamivudine and abacavir

קניה - אנגלית - Pharmacy and Poisons Board

aurobindo pharma ltd aurobindo - abacavir sulfate usp and lamivudine usp - film-coated tablet - abacavir sulfate 600 mg and lamivudine 300 mg - lamivudine and abacavir

מלטה - אנגלית - Medicines Authority

teva b.v. swensweg 5, 2031 ga haarlem, netherlands - abacavir, lamivudine - film-coated tablet - abacavir 600 mg lamivudine 300 mg - antivirals for systemic use

מלטה - אנגלית - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - abacavir - film-coated tablet - abacavir 300 mg - antivirals for systemic use

אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - abacavir - film-coated tablet - 300 milligram(s) - abacavir

מלטה - אנגלית - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - abacavir, lamivudine - film-coated tablet - abacavir 600 mg lamivudine 300 mg - antivirals for systemic use

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - abacavir sulfate,lamivudine -

ארצות הברית - אנגלית - NLM (National Library of Medicine)

stat rx usa - lamivudine (unii: 2t8q726o95) (lamivudine - unii:2t8q726o95), zidovudine (unii: 4b9xt59t7s) (zidovudine - unii:4b9xt59t7s) - lamivudine 150 mg - combivir, a combination of two nucleoside analogues, is indicated in combination with other antiretrovirals for the treatment of hiv-1 infection. combivir tablets are contraindicated in patients with previously demonstrated clinically significant hypersensitivity (e.g., anaphylaxis, stevens-johnson syndrome) to any of the components of the product. pregnancy category c. fetal risk summary: there are no adequate and well-controlled studies of combivir (lamivudine and zidovudine) in pregnant women. clinical trial data demonstrate that maternal zidovudine treatment during pregnancy reduces vertical transmission of hiv-1 infection to the fetus. animal reproduction studies performed with lamivudine and zidovudine showed increased embryotoxicity and fetal malformations (zidovudine), and increased embryolethality (lamivudine). combivir should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. antiretroviral pregnancy registry: to monitor maternal-fetal outc

ארצות הברית - אנגלית - NLM (National Library of Medicine)

state of florida doh central pharmacy - abacavir sulfate (unii: j220t4j9q2) (abacavir - unii:wr2tip26vs) - abacavir sulfate 300 mg - ziagen tablets and oral solution, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus (hiv-1) infection. additional important information on the use of ziagen for treatment of hiv-1 infection: - ziagen is one of multiple products containing abacavir. before starting ziagen, review medical history for prior exposure to any abacavir-containing product in order to avoid reintroduction in a patient with a history of hypersensitivity to abacavir. ziagen is contraindicated in patients with previously demonstrated hypersensitivity to abacavir or any other component of the products. never restart ziagen or any other abacavir-containing product following a hypersensitivity reaction to abacavir, regardless of hla-b*5701 status [see warnings and precautions (5.1), adverse reactions (6)] . ziagen is contraindicated in patients with moderate or severe hepatic impairment. pregnancy category c. studies in pregnant rats showed that abacavir is transferred to the fe